Literature DB >> 17238018

Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models.

Masae Tatematsu1, Tetsuya Tsukamoto, Takeshi Toyoda.   

Abstract

Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils (MGs) treated with N-methyl-N'-nitro-N-nitrosoguanidine and N-methyl-N-nitrosourea. A high-salt diet has been revealed to synergistically enhance development of stomach cancer with H. pylori infection; the latter exerts stronger promoting effects than the former. Eradication of H. pylori with antibiotics diminishes their enhancing effects. The earlier the eradication of H. pylori is undergone, the more effective is the prevention of gastric carcinogenesis in MGs. To explore whether the role of H. pylori infection is a cause of stomach carcinogenesis (initiator) or just a supporting actor (promoter), we established an experimental model of long-term (2 years) H. pylori infection and eradication in MGs without chemical carcinogens. Long-term H. pylori infection stimulated development of highly proliferative and dilated glands containing a large amount of mucin, called heterotopic proliferative glands (HPGs), resembling mucinous adenocarcinomas. However, no gastric carcinomas were found in MGs after 2 years of H. pylori infection in our system. After eradication of the bacteria, HPGs were obviously reduced, and gastric lesions were mostly alleviated. These findings showed that H. pylori infection is related to severe gastritis and that HPGs are frequently induced reversible lesions rather than being malignant in character. Helicobacter pylori infection thus appears to have a strong promotional influence but not to initiate gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238018     DOI: 10.1007/s00535-006-1927-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens.

Authors:  N Shimizu; K Inada; H Nakanishi; T Tsukamoto; Y Ikehara; M Kaminishi; S Kuramoto; A Sugiyama; T Katsuyama; M Tatematsu
Journal:  Carcinogenesis       Date:  1999-04       Impact factor: 4.944

2.  Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils.

Authors:  F Hirayama; S Takagi; E Iwao; Y Yokoyama; K Haga; S Hanada
Journal:  J Gastroenterol       Date:  1999-08       Impact factor: 7.527

3.  High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells.

Authors:  Sosuke Kato; Tetsuya Tsukamoto; Tsutomu Mizoshita; Harunari Tanaka; Toshiko Kumagai; Hiroyoshi Ota; Tsutomu Katsuyama; Masahiro Asaka; Masae Tatematsu
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

4.  Establishment of gastric Helicobacter pylori infection in Mongolian gerbils.

Authors:  F Hirayama; S Takagi; Y Yokoyama; E Iwao; Y Ikeda
Journal:  J Gastroenterol       Date:  1996-11       Impact factor: 7.527

5.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

6.  Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.

Authors:  S Honda; T Fujioka; M Tokieda; R Satoh; A Nishizono; M Nasu
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

7.  Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.

Authors:  Koji Nozaki; Nobuyuki Shimizu; Yuzuru Ikehara; Manami Inoue; Tetsuya Tsukamoto; Ken-ichi Inada; Harunari Tanaka; Toshiko Kumagai; Michio Kaminishi; Masae Tatematsu
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

8.  Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils.

Authors:  Koji Nozaki; Nobuyuki Shimizu; Ken-ichi Inada; Tetsuya Tsukamoto; Manami Inoue; Toshiko Kumagai; Atsushi Sugiyama; Tsutomu Mizoshita; Michio Kaminishi; Masae Tatematsu
Journal:  Jpn J Cancer Res       Date:  2002-10

9.  Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine in drinking water.

Authors:  M Tatematsu; M Yamamoto; N Shimizu; A Yoshikawa; H Fukami; M Kaminishi; T Oohara; A Sugiyama; T Ikeno
Journal:  Jpn J Cancer Res       Date:  1998-02

10.  Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication.

Authors:  Koji Nozaki; Nobuyuki Shimizu; Tetsuya Tsukamoto; Ken-Ichi Inada; Xueyuan Cao; Yuzuru Ikehara; Michio Kaminishi; Atsushi Sugiyama; Masae Tatematsu
Journal:  Jpn J Cancer Res       Date:  2002-04
View more
  5 in total

1.  Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?

Authors:  Richard M Peek
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  Youngest case of an early gastric cancer after successful eradication therapy.

Authors:  Hironori Konuma; Ichiro Konuma; Kuangi Fu; Satoshi Yamada; Yutaka Suzuki; Akihisa Miyazaki
Journal:  World J Gastrointest Endosc       Date:  2013-06-16

Review 3.  Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers.

Authors:  Young-Min Han; Jong-Min Park; Ho-Jae Lee; Eun-Hee Kim; Ki Baik Hahm
Journal:  J Cancer Prev       Date:  2013-12

Review 4.  Murine Models of Gastric Corpus Preneoplasia.

Authors:  Christine P Petersen; Jason C Mills; James R Goldenring
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-11-16

5.  Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial.

Authors:  Masafumi Maruyama; Naoki Tanaka; Daisuke Kubota; Masayuki Miyajima; Takefumi Kimura; Koujiro Tokutake; Ryujiro Imai; Toru Fujisawa; Hiromitsu Mori; Yoshiaki Matsuda; Shuichi Wada; Akira Horiuchi; Kendo Kiyosawa
Journal:  Can J Gastroenterol Hepatol       Date:  2017-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.